Literature DB >> 8058309

Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines.

S Yamashiro1, T Urano, H Shiku, K Furukawa.   

Abstract

The nm23-H1 gene is regarded as a human homologue of the mouse nm23 gene, which was expressed in a non-metastatic subline of mouse melanoma K-1735. The expression levels of nm23-H1 mRNA and the levels of protein during induced differentiation of human leukemia cell lines were analysed. mRNA levels of the megakaryoblastic leukemia line MEG-01, which were induced to differentiate into megakaryocyte by TPA, decreased rapidly from 2 days after the start of treatment and became almost undetectable at day 4. Similar down-regulation of nm23-H1 mRNA was also observed in the induced differentiation of the promyelocytic leukemia line HL-60 by TPA, or DMSO into monocyte-macrophage lineage or granulocytes, respectively. The amount of Nm23-H1 protein was analysed by Western immuno-blot analysis using mouse antiserum raised against a recombinant fusion protein with glutathione S-transferase. The amount of Nm23-H1 protein also decreased during the induced differentiation of these leukemia cell lines. On the other hand, in the differentiation of the erythroleukemia line K562 by hemin, levels of both mRNA and protein of Nm23-H1 elevated transiently, then reduced to the original level. When MEG-01 and K562 were stably transfected with nm23-H1 cDNA, MEG-01 transfectants showed reduced sensitivity to the induction of differentiation, whereas K562 transfectants were better induced to synthesize hemoglobin than controls. These findings suggest the possibility that Nm23-H1 protein plays an important role to maintain the proliferation of immature leukemic cells in MEG-01 and HL-60, but it may also play a role in the early stage of K562 differentiation, possibly in the different manner.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058309

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Extracellular NME proteins: a player or a bystander?

Authors:  Patrizia Romani; Marilena Ignesti; Giuseppe Gargiulo; Tien Hsu; Valeria Cavaliere
Journal:  Lab Invest       Date:  2017-10-16       Impact factor: 5.662

Review 2.  Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives.

Authors:  Yuanjun Li; Yao Tong; Yung H Wong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-21       Impact factor: 3.000

Review 3.  The human Nm23/nucleoside diphosphate kinases.

Authors:  M L Lacombe; L Milon; A Munier; J G Mehus; D O Lambeth
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

4.  Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.

Authors:  Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; Hirofumi Kobayashi; Nobuo Maseki; Yasuhiko Kaneko
Journal:  Int J Hematol       Date:  2009-08-05       Impact factor: 2.490

5.  Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells.

Authors:  D Venturelli; R Martinez; P Melotti; I Casella; C Peschle; C Cucco; G Spampinato; Z Darzynkiewicz; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

6.  Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies.

Authors:  Junko Okabe-Kado; Takashi Kasukabe; Yasuhiko Kaneko
Journal:  Adv Hematol       Date:  2011-09-19

7.  Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.

Authors:  N Wakimoto; A Yokoyama; J Okabe-Kado; N Nagata; K Motoyoshi; Y Honma
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.